account30 a.m. EDT NEW YORK, NY and SAN FRANCISCO, CA, Apr 11, 2011 (MARKETWIRE via COMTEX) -- Pfizer Inc /quotes/comstock/13*!pfe/quotes/nls/pfe (PFE 20.46, +0.13, +0.64%) and Medivation, Inc. /quotes/comstock/15*!mdvn/quotes/nls/mdvn (MDVN 20.11, +0.05,...
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
Reactions to Pfizer and Medivation Announce Results From Phase 3 Horizon Trial of Dimebon in Huntington Disease
Join Business Exchange
to access the most relevant content for you, filtered by like-minded business professionals. Learn more
account